15-18 April Liverpool
![]() |
![]() |
![]() |
![]() |
P-059 | Distinguishing prostate cancer grades using X-ray and spectroscopic analysis of calcifications | Sarah Gosling | ![]() |
![]() |
|||
P-067 | Influence of vitamin D and vitamin K metabolite concentrations on different bone mineral densities in postmenopausal women | Sieglinde Zelzer | ![]() |
![]() |
|||
P-085 | Alterations in bone intrinsic and compositional properties at the cement lines in interstitial bone of postmenopausal women diagnosed with long-term Type-1 Diabetes | Sonja Gamsjaeger | ![]() |
![]() |
|||
P-095 | Psychostimulant Prescription, Prevalence, and Recovery Following Distal Radius Fractures in a Pediatric Population | Thomas Carroll | ![]() |
![]() |
|||
P-103 | Humanin treatment prevents bone growth impairment caused by venetoclax in cultured rat metatarsal bones | Lilly Velentza | ![]() |
![]() |
|||
P-111 | MechanoChip A novel mechanobiology-based drug screening in vitro platform for bone metastases | Cornelia Bratengeier | ![]() |
![]() |
|||
P-120 | Medical management is a viable alternative in tumour induced osteomalacia with failed tumour localisation | Abhranil Dhar | ![]() |
![]() |
|||
P-121 | Simultaneous inhibition of Myostatin and Activin A effectively reduces osteoclast-mediated bone loss in a xenograft mouse model of breast cancer metastasis | Corinna Wehmeyer | ![]() |
![]() |
|||
P-154 | Epigenome-wide DNA methylation in octogenarians: BMD and fracture outcomes | Fiona E McGuigan | ![]() |
![]() |
|||
P-157 | A new node of transcription factors regulating the equilibrium between osteoblastogenesis and adipogenesis. | Ana Alonso-Pérez | ![]() |
![]() |
|||
P-163 | Calcinosis cutis independent risk factor for all-cause mortality in autoimmune rheumatic diseases | Cristina Nita | ![]() |
![]() |
|||
P-170 | Reactive Arthritis following COVID-19 infection: Case Series | Maria Lolou | ![]() |
![]() |
|||
P-173 | The effect of intra-articular injection of hyaluronic acid for mild to moderate knee osteoarthritis in rheumatoid arthritis patients | Dimitrios Giotis | ![]() |
![]() |
|||
P-180 | Tapering Denosumab to discontinuation a new strategy to avoid the rebound phenomenon? Nine case reports | Tove Tveitan Borgen | ![]() |
![]() |
|||
P-218 | Preventing abnormal bone growth: a new therapy for heterotopic ossification | Ana Alonso-Pérez | ![]() |
![]() |
|||
P-225 | Hordenine inhibits bone resorption via regulation of calcium homeostasis | JIHEE KIM | ![]() |
![]() |
|||
P-226 | Transcriptomic differences underlying the Activin-A induced large osteoclast formation | Ton Schoenmaker | ![]() |
![]() |
|||
P-230 | The effect of sclerostin and monoclonal sclerostin antibody Romosozumab on osteogenesis and osteoclastogenesis mediated by periodontal ligament fibroblasts | Teun de Vries | ![]() |
![]() |
|||
P-238 | Bone mineral density, trabecular bone score (TBS) and body-fat analysis in type 1 diabetes by DXA and co-relation with biochemical parameters; case-control study from India | Shinjan Patra | ![]() |
![]() |
|||
P-257 | A potential role of hepcidin deficiency in the occurrence of iron related osteoporosis. Genetic and secondary iron overload mouse models induce differences in with. | Franois ROBIN | ![]() |
![]() |
|||
P-260 | Sustained Hypophosphatemia after Denosumab in a Chronic Kidney Disease patient on Hemodialysis | Ahmed A.S. Almodares | ![]() |
![]() |
|||
P-264 | Dosing of intermittent iv. Zoledronic acid based on bone turnover marker assessment preserves bone mineral density over eight years | Erik Fink Eriksen | ![]() |
![]() |
|||
P-274 | Eldecalcitol prevented OVX-induced osteoporosis through inhibiting BMSCs senescence by regulating the SIRT1-Nrf2 signal | hongrui liu | ![]() |
![]() |
|||
P-292 | Neurogenic Heterotopic Ossification Deconstruction: a New in vitro Model Reveals Nerve System-Derived Factors Modulate Osteoblast and Adipocyte Metabolism | María Guillán-Fresco | ![]() |
![]() |
|||
P-314 | Pharmacokinetics and Pharmacodynamics of Garetosmab in Patients with Fibrodysplasia Ossificans Progressiva | de Ruiter Ruben | ![]() |
![]() |
|||
P-315 | Characterisation of New Heterotopic Ossification Lesions in Patients with Fibrodysplasia Ossificans Progressiva by PET/CT vs CT Only | Gonzalez Trotter Dinko | ![]() |
![]() |
|||
P-316 | Treatment with the PI3Kalpha inhibitor BYL719 unveils a differential regulation of AP-1 by Activin in Fibrodysplasia ossificans progressiva | Gonzalo Sanchez-Duffhues | ![]() |
![]() |
|||
P-322 | Osteoporosis and knock knee in a tall young man: A rare case of aromatase deficiency | Pankaj Singhania | ![]() |
![]() |
|||
P-326 | Generation of the first Progressive Osseous Heteroplasia in vitro model from a patient with a GNAS de novo mutation | María Piñeiro-Ramil | ![]() |
![]() |
15-18 April Liverpool
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|